Scripps Health’s Post

Facing a cancer diagnosis is never easy, but ensuring that you have the best possible treatment plan in place can help ease the overwhelm. At Capital Health Cancer Center, we’re committed to providing second opinions for those who have been previously diagnosed with cancer or who suspect they’re showing symptoms of it. Learn what to expect when seeking a second opinion and why getting one is so important: https://bit.ly/4hybNSa

Learn how you can make a difference during Cancer Control Month by reading our blog: https://bit.ly/43Hbm1l

Can patients with difficult-to-treat solid cancers, like glioblastoma, use immunotherapies to get a durable response? An immunotherapy fights the cancer system with the immune system, and the side effects can be more appealing than the side effects of other treatments, like chemotherapy, which weakens the immune system. One immunotherapy is a personalized cancer vaccine, which is attractive because it offers a possible treatment option to nearly every cancer patient. Personalized cancer vaccines can be used to introduce or stimulate selected T cells (a kind of white blood cell, part of the immune system) to attack cancer cells. A personalized cancer vaccine leverages the immune system's ability to see self/normal versus non-self/foreign cells and attack the non-self/foreign cells through a tailored antitumor response to their tumor mutation signature. The vaccine is trying to get your body to produce enough of the right T cells, and then combine it with other personalized drug combinations to make sure that those T cells can do their job and win the battle against the tumor. Another immunotherapy technology that is similar is “tumor infiltrating lymphocytes” (TIL), where they take your tumor sample, find the T cells that are in that sample, verify that those T cells are the ones that are supposed to be there doing the job, then expand those and inject them back into the patient. For more on immunotherapies and a novel T cell therapy being applied to glioblastoma, please see our discussion with Wayne Carter, DVM, PhD, President and CEO, TVAX Biomedical here: https://lnkd.in/e9jjtcR8

Sumit Rai gives a closer look at the blood tests for early detection of cancer. Cancer is completely indiscriminate and the cause of a lot of anxiety, pain, suffering, and loss. The best way to be present for those big moments in life with your family and friends is to stay ahead of cancer. Screen early, screen today. https://lnkd.in/eHqJBZNz

Lung cancer is a incredibly deadly but it's a foe we can defeat. The timing of diagnosis is crucial in determining a patient’s survivability and is directly tied to how advanced the disease is when detected. Our latest blog post delves into the obstacles healthcare providers encounter and explores avenues to improve access to early detection. 🫁💜🤍 #LungCancer #EarlyDetection #GalaxySystem

In today's post we conclude our discussion of cancer screening with a focus on MCEDs (multicancer early detection tests). Will we be screening everyone for all cancers with a simple blood test?

These trial results are truly encouraging. For patients battling advanced lung cancer, the combination of amivantamab and lazertinib is offering not just longer survival but real hope. Extending the time without cancer progression by over 40% gives families precious moments together. Though side effects like rashes or infections are common, the benefits are hard to ignore. This is another reminder of how far precision medicine has come, targeting specific cancer drivers and making a real difference in people’s lives. #lungscreen #precision #diagnosis

A new at-home blood test device, Liberty, has received regulatory approval. This device allows cancer patients to perform blood tests at home, reducing the need for hospital visits and potentially increasing NHS efficiency. Initial trials at The Christie have shown positive results, though Cancer Research UK stresses the need for further research due to limited trial sizes. How do you think this innovation will impact cancer care? #PublicHealth #CancerCare #HealthTech #NHS #MedicalInnovation 🔗 Read more

#Liquidbiopsies continue to be a valuable tool for monitoring Minimal Residual Disease. It is great to see continued progress and hopefully these tools are employed more in the clinic for improved patient outcomes. #prostatecancer #precisiononcology #precisionmedicine #cancer

🌟 NEW BLOG! Harpar Grace International Launches iS CLINICAL Advanced Cancer Care Programme 🌟 The iS Clinical Advanced Cancer Care Programme is offering free training for spas to support clients undergoing cancer treatment. This initiative empowers professionals with the knowledge and tools to deliver safe, effective, and compassionate care, ensuring a more inclusive experience for all clients. Discover how this programme is transforming spa services for those on their cancer journey: 🔗https://lnkd.in/egcGkkqB #Aesthetics #Wellness #CancerCare #InclusiveBeauty #ProfessionalDevelopment